Evidence map›Paper›PMID 39696055›Full record

ArticleBMC ophthalmology2024

Management and toxicological analysis of ocular hypertension after EyeCee

Paul Bastelica, Romain Magny, Joël Poupon, Bertrand Sonigo, Tristan Aubert, Françoise Brignole-Baudouin, Juliette Buffault, Christophe Baudouin, Antoine Labbé

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Paul BastelicaDepartment 3, 15-20 National Vision Hospital, IHU FOReSIGHT, 28 rue de Charenton, Paris, 75012, France. pbastelica@15-20.fr.
Romain MagnyToxicology-Biology Department, Saint-Louis - Lariboisière - Fernand Widal Group, 2 rue Ambroise Paré, Paris, 75475, France.
Joël PouponToxicology-Biology Department, Saint-Louis - Lariboisière - Fernand Widal Group, 2 rue Ambroise Paré, Paris, 75475, France.
Bertrand SonigoSaint Germain Vision Eye Center, 30 bis rue du Vieil Abreuvoir, Saint-Germain- en-Laye, 78100, France.
Tristan AubertDepartment 3, 15-20 National Vision Hospital, IHU FOReSIGHT, 28 rue de Charenton, Paris, 75012, France.
Françoise Brignole-BaudouinDepartment 3, 15-20 National Vision Hospital, IHU FOReSIGHT, 28 rue de Charenton, Paris, 75012, France.
Juliette BuffaultDepartment 3, 15-20 National Vision Hospital, IHU FOReSIGHT, 28 rue de Charenton, Paris, 75012, France.
Christophe BaudouinDepartment 3, 15-20 National Vision Hospital, IHU FOReSIGHT, 28 rue de Charenton, Paris, 75012, France.
Antoine LabbéDepartment 3, 15-20 National Vision Hospital, IHU FOReSIGHT, 28 rue de Charenton, Paris, 75012, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe EyeCee CASES PRESENTATION: Five patients developed early, severe OHT refractory to maximal medical therapy following uneventful phacoemulsification (PCE) cataract surgery with implantation of an EyeCee

conclusionsThese cases of OHT following cataract surgery with a defective IOL were of early onset severe, all requiring filtering surgery. The exact mechanism of this OHT has not been determined, but we did find high concentrations of silicon in the aqueous humor of one of these patients. Patients who received EyeCee

Indexed as

Intraocular PressureLenses, IntraocularLens Implantation, IntraocularOcular HypertensionPhacoemulsificationAgedAged, 80 and overAqueous HumorFemaleHumansMaleMiddle AgedPostoperative ComplicationsProsthesis FailureSiliconSiliconGlaucomaIntraocular lensOcular hypertensionPhacoemulsificationToxicology

Identifiers

PMID39696055
PMCPMC11654199

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.